Dendrite Appoints Carl L. Cohen as President of Marketing Solutions

Dendrite International, Inc. (NASDAQ:DRTE) a leading
provider of pharmaceutical industry solutions, today announced the
appointment of Carl L. Cohen as President of its Marketing Solutions
division. Mr. Cohen is an integral addition to Dendrite's new
management team and will be responsible for driving this rapidly
growing division.
   Mr. Cohen joins Dendrite from Starwood Hotels and Resorts
Worldwide, one of the largest hotel chains in the world, where he most
recently served as Senior Vice President. Mr. Cohen held several
strategic positions during his tenure at Starwood, including running
its software and services division and starting a profitable broadband
business unit. He also led many crucial initiatives, notably the
creation of a new reservation and loyalty marketing system for the
hotel chain.
   Previously, Mr. Cohen served as Chief Marketing Officer at
Wrenchhead.com and Executive Vice President of Marketing for
Championship Auto Racing Teams, a global brand in auto sports. During
his career, Mr. Cohen has held several senior marketing and brand
management leadership positions at companies such as Philip Morris,
Colgate Palmolive and Reckitt & Coleman.
   "Based on the products and services available today and those
coming in the future, the Marketing Solutions division at Dendrite is
poised for explosive growth on a global scale," said Mr. Cohen. "The
opportunity to join Dendrite at this exciting time, to help lead this
innovative division, was one that I could not resist."
   "Carl will bring a fresh perspective to Dendrite from a successful
career that has spanned more than 20 years in a wide range of
industries," said Joseph Ripp, president and COO of Dendrite. "We're
looking forward to Carl's contributions, including spearheading the
kind of new thinking and approaches that will be instrumental to
Dendrite as we continue to forge a leadership path."
   Mr. Cohen is a graduate of SUNY at Albany and earned his Master's
of Business Administration from The Wharton School of the University
of Pennsylvania.

   About Dendrite

   Founded in 1986, Dendrite International (NASDAQ: DRTE) enables
sales, marketing, clinical and compliance solutions for the global
pharmaceutical industry. The Company's clients are located in more
than 50 countries and include the world's top 20 pharmaceutical
companies. For more information, please visit www.dendrite.com.

   Note: Dendrite is a registered trademark of Dendrite
International, Inc.

   This document may contain forward-looking statements that may be
identified by such forward-looking terminology as "expect," "believe,"
"anticipate," "will," "intend," "plan," "target," "outlook,"
"guidance," and similar statements or variations. Such forward-looking
statements are based on our current expectations, estimates,
assumptions and projections and involve significant risks and
uncertainties, including risks which may result from our dependence on
the pharmaceutical industry; fluctuations in quarterly revenues due to
lengthy sales and implementation cycles for certain of our solutions;
our fixed expenses in relation to fluctuating revenues and variations
in customers' budget cycles; dependence on certain major customers;
changes in demand for our products and services attributable to any
weakness experienced in the economy or mergers, acquisitions and
consolidations in the pharmaceutical industry; successful and timely
development and introduction of new products and versions; rapid
technological changes; increased competition; international
operations; integrating the entities we acquire; our ability to
effectively manage our growth; the protection of our proprietary
technology; our ability to compete in the Internet-related products
and services market; the continued demand for Internet-related
products and services; the ability of our third party vendors to
respond to technological change; our ability to maintain our
relationships with third-party vendors; less favorable than
anticipated results from strategic relationships; dependence of data
solutions on strategic relationships; events which may affect the U.S.
and world economies; and catastrophic events which could negatively
affect our information technology infrastructure. Other important
factors that should be reviewed and carefully considered are included
in the company's 10-K, 10-Qs, and other reports filed with the SEC.
Actual results may differ materially. The company assumes no
obligation for updating any such forward-looking statements to reflect
actual results, changes in assumptions or other changes affecting such
forward-looking statements.